Literature DB >> 8988043

DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.

W K Rathmell1, W K Kaufmann, J C Hurt, L L Byrd, G Chu.   

Abstract

In response to DNA damage, cells transduce a signal that leads to accumulation and activation of p53 protein, transcriptional induction of several genes, including p21, gadd45, and gadd153, and cell cycle arrest. One hypothesis is that the signal is mediated by DNA-dependent protein kinase (DNA-PK), which consists of a catalytic subunit (DNA-PKcs) and a regulatory subunit (Ku). DNA-PK has several characteristics that support this hypothesis: Ku binds to DNA damaged by nicks or double-strand breaks, DNA-PKcs is activated when Ku binds to DNA, DNA-PK will phosphorylate p53 and other cell cycle regulatory proteins in vitro, and DNA-PKcs shares homology with ATM, which is mutated in ataxia telangiectasia and involved in signaling the p53 response to ionizing radiation. The hypothesis was tested by analyzing early passage fibroblasts from severe combined immunodeficient mice, which are deficient in DNA-PK. After exposure to ionizing radiation, UV radiation, or methyl methane-sulfonate, severe combined immunodeficient and wild-type cells were indistinguishable in their response. The accumulation of p53, induction of p21, gadd45, and gadd153, and arrest of the cell cycle in G1 and G2 occurred normally. Therefore, DNA-PK is not required for the p53 response or cell cycle arrest after DNA damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988043

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest.

Authors:  S Wang; M Guo; H Ouyang; X Li; C Cordon-Cardo; A Kurimasa; D J Chen; Z Fuks; C C Ling; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.

Authors:  K Nakagawa; Y Taya; K Tamai; M Yamaizumi
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Quaternary structure of ATR and effects of ATRIP and replication protein A on its DNA binding and kinase activities.

Authors:  Keziban Unsal-Kaçmaz; Aziz Sancar
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro.

Authors:  H Lu; R P Fisher; P Bailey; A J Levine
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 5.  The human intra-S checkpoint response to UVC-induced DNA damage.

Authors:  William K Kaufmann
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

6.  p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity.

Authors:  B J Hwang; S Toering; U Francke; G Chu
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair.

Authors:  B J Hwang; J M Ford; P C Hanawalt; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  UV sensitivity and impaired nucleotide excision repair in DNA-dependent protein kinase mutant cells.

Authors:  C Muller; P Calsou; P Frit; C Cayrol; T Carter; B Salles
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

9.  The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase.

Authors:  C Jhappan; T M Yusufzai; S Anderson; M R Anver; G Merlino
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 10.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.